New Drug: Odevixibat for progressive familial intrahepatic cholestasis and Alagille syndrome-associated cholestatic pruritus

Australian Prescriber · Published 2026-07-29 · DOI 10.18773/austprescr.2026.031

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.18773/austprescr.2026.031

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• New Drug: Spesolimab for generalised pustular psoriasis · Australian Prescriber · 2025 · Same journal
• Cardio-kidney-metabolic (CKM) syndrome · Australian Prescriber · 2026 · Same journal
• Using pharmacogenomics to personalise drug therapy: which drugs, when and how · Australian Prescriber · 2025 · Same journal
• Top 10 drugs 2024–25 · Australian Prescriber · 2025 · Same journal
• Preventing infections in immunosuppressed patients · Australian Prescriber · 2026 · Same journal
• Aminoglycosides: an update on indications, dosing and monitoring · Australian Prescriber · 2025 · Same journal
• New Drug: Edaravone for amyotrophic lateral sclerosis · Australian Prescriber · 2025 · Same journal
• New Drug: Fenfluramine for seizures associated with Dravet syndrome and Lennox–Gastaut syndrome · Australian Prescriber · 2025 · Same journal
• Acne vulgaris: a clinical update · Australian Prescriber · 2026 · Same journal
• Medicinal Mishap: Near-fatal reaction associated with cotrimoxazole, metformin and kidney impairment · Australian Prescriber · 2025 · Same journal